There will be no hometown discount for Adrian Gonzalez

0 Comments

It’s long seemed obvious that Adrian Gonzalez won’t be signing a mutli-year extension with the Padres. The real question is how long into his current, very reasonable deal the Padres will keep him before putting him on the market. But in the unlikely event that the Padres do look to keep him around long term, they shouldn’t expect any bargains.

“This next contract is going to be the contract I think I deserve,” Gonzalez said today, while also confirming that there were no
current discussions between his agent and the team.  He added that he “wants to win as a Padre more than anything else” but that he has no sense of what his future holds.

While he may not be on quite the same level as Joe Mauer and Albert Pujols, he’s the unquestionable face of the Padres and the most important player on that team since Tony Gwynn retired.  In light of this I wish people would offer the same “I think it be best for the team if he stayed put . . .” disclaimers when discussing Gonzalez’s future that they do for Mauer and Pujols.

MLB, union resume blood testing after pandemic, lockout

Scott Taetsch-USA TODAY Sports
1 Comment

NEW YORK – In the first acknowledgment that MLB and the players’ association resumed blood testing for human growth hormone, the organizations said none of the 1,027 samples taken during the 2022 season tested positive.

HGH testing stopped in 2021 because of the COVID-19 pandemic. Testing also was halted during the 99-day lockout that ended in mid-March, and there were supply chain issues due to COVID-19 and additional caution in testing due to coronavirus protocols.

The annual public report is issued by Thomas M. Martin, independent program administrator of MLB’s joint drug prevention and treatment program. In an announcement accompanying Thursday’s report, MLB and the union said test processing is moving form the INRS Laboratory in Quebec, Canada, to the UCLA Laboratory in California.

MLB tests for HGH using dried blood spot testing, which was a change that was agreed to during bargaining last winter. There were far fewer samples taken in 2022 compared to 2019, when there were 2,287 samples were collected – none positive.

Beyond HGH testing, 9,011 urine samples were collected in the year ending with the 2022 World Series, up from 8,436 in the previous year but down from 9,332 in 2019. And therapeutic use exemptions for attention deficit hyperactivity disorder dropped for the ninth straight year, with just 72 exemptions in 2022.

Overall, the league issued six suspensions in 2022 for performance-enhancing substances: three for Boldenone (outfielder/first baseman Danny Santana, pitcher Richard Rodriguez and infielder Jose Rondon, all free agents, for 80 games apiece); one each for Clomiphene (Milwaukee catcher Pedro Severino for 80 games), Clostebol (San Diego shortstop Fernando Tatis Jr. for 80 games) and Stanozolol (Milwaukee pitcher J.C. Mejia for 80 games).

There was an additional positive test for the banned stimulant Clobenzorex. A first positive test for a banned stimulant results in follow-up testing with no suspension.